Invention Grant
US08852650B2 Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
有权
使用BBI / BBIC治疗肌肉萎缩和退行性肌肉疾病
- Patent Title: Use of BBI/BBIC for treatment of muscular atrophy and degenerative muscle disease
- Patent Title (中): 使用BBI / BBIC治疗肌肉萎缩和退行性肌肉疾病
-
Application No.: US13211855Application Date: 2011-08-17
-
Publication No.: US08852650B2Publication Date: 2014-10-07
- Inventor: H. Lee Sweeney , Carl A. Morris , Ann R. Kennedy
- Applicant: H. Lee Sweeney , Carl A. Morris , Ann R. Kennedy
- Applicant Address: US PA Philadelphia
- Assignee: The Trustees of the University of Pennsylvania
- Current Assignee: The Trustees of the University of Pennsylvania
- Current Assignee Address: US PA Philadelphia
- Agency: Licata & Tyrrell P.C.
- Main IPC: A01N65/00
- IPC: A01N65/00 ; A61K38/56
Abstract:
Methods for use of a composition comprising Bowman-Birk Inhibitor (BBI) or a derivative thereof in the treatment and/or prevention of skeletal muscle atrophy, to improve of skeletal muscle function, and to alleviate symptoms and/or slow progression of degenerative skeletal muscle diseases or disorders are provided.
Public/Granted literature
- US20110301075A1 Use of BBI/BBIC for Treatment of Muscular Atrophy and Degenerative Muscle Disease Public/Granted day:2011-12-08
Information query
